Challenges in Optimizing Nanoplatforms Used for Local and Systemic Delivery in the Oral Cavity.

microneedles nanocarrier nanoparticles nanoplatforms oral pathology transdermal drug delivery

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
07 May 2024
Historique:
received: 19 03 2024
revised: 03 05 2024
accepted: 04 05 2024
medline: 25 5 2024
pubmed: 25 5 2024
entrez: 25 5 2024
Statut: epublish

Résumé

In this study, we focused on innovative approaches to improve drug administration in oral pathology, especially by transmucosal and transdermal pathways. These improvements refer to the type of microneedles used (proposing needles in the saw), to the use of certain enhancers such as essential oils (which, besides the amplifier action, also have intrinsic actions on oral health), to associations of active substances with synergistic action, as well as the use of copolymeric membranes, cemented directly on the tooth. We also propose a review of the principles of release at the level of the oral mucosa and of the main release systems used in oral pathology. Controlled failure systems applicable in oral pathology include the following: fast dissolving films, mucoadhesive tablets, hydrogels, intraoral mucoadhesive films, composite wafers, and smart drugs. The novelty elements brought by this paper refer to the possibilities of optimizing the localized drug delivery system in osteoarthritis of the temporomandibular joint, neuropathic pain, oral cancer, periodontitis, and pericoronitis, as well as in maintaining oral health. We would like to mention the possibility of incorporating natural products into the controlled failure systems used in oral pathology, paying special attention to essential oils.

Identifiants

pubmed: 38794288
pii: pharmaceutics16050626
doi: 10.3390/pharmaceutics16050626
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Auteurs

Dorin Ioan Cocoș (DI)

Centre in the Medical-Pharmaceutical Field, Faculty of Medicine and Pharmacy, "Dunarea de Jos" the University of Galati, 800008 Galati, Romania.

Olimpia Dumitriu Buzia (O)

Centre in the Medical-Pharmaceutical Field, Faculty of Medicine and Pharmacy, "Dunarea de Jos" the University of Galati, 800008 Galati, Romania.

Alin Laurențiu Tatu (AL)

Clinical Medical Department, Faculty of Medicine and Pharmacy, "Dunarea de Jos" University, 800008 Galati, Romania.
Dermatology Department, "Sf. Cuvioasa Parascheva" Clinical Hospital of Infectious Diseases, 800179 Galati, Romania.
Multidisciplinary Integrative Center for Dermatologic Interface Research MIC-DIR, 800010 Galati, Romania.

Monica Dinu (M)

Centre in the Medical-Pharmaceutical Field, Faculty of Medicine and Pharmacy, "Dunarea de Jos" the University of Galati, 800008 Galati, Romania.

Lawrence Chukwudi Nwabudike (LC)

N. Paulescu Institute, 030167 Bucharest, Romania.

Claudia Simona Stefan (CS)

Centre in the Medical-Pharmaceutical Field, Faculty of Medicine and Pharmacy, "Dunarea de Jos" the University of Galati, 800008 Galati, Romania.

Kamel Earar (K)

Centre in the Medical-Pharmaceutical Field, Faculty of Medicine and Pharmacy, "Dunarea de Jos" the University of Galati, 800008 Galati, Romania.

Carmen Galea (C)

Department of Medical Disciplines, Faculty of Dental Medicine, University of Targu Mures, 540099 Targu Mures, Romania.

Classifications MeSH